Novartis Price Fixing, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
DURECT Corporation (DRRX)
Last durect corporation earnings: 3/3 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
durect.com/investors
Company Research
Source: Seeking Alpha
Summary Novartis agrees to pay in settlement for its subsidiary Sandoz' price fixing issue. Durect reports results. Centene tanks on guidance. Centene Provides Guidance Update, Stock Tanks Centene Corp. ( CNC undergo Centene had provided its fourth quarter and full year results in the month of February. The company reported The company recently completed its acquisition of WellCare, valued at nearly $19.6 billion, including the assumption of debt. The combined entity will focus on government sponsored healthcare program. Centene expects its health benefits ratio to be in the range of 85.9 percent and 86.3 percent. The company's selling, general and administrative expense ratio is expected to be between 8.9 percent and 9.3 percent. As for its guidance update, the company Durect Reports Full Year Results, Gets DUR-928 Boost Durect Corporation ( DRRX GILD Durect announced its fourth quarter revenue at $10.7 million while its full year revenue stood at $29.6 million. It reported its net l
Show less
Read more
Impact Snapshot
Event Time:
DRRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRRX alerts
High impacting DURECT Corporation news events
Weekly update
A roundup of the hottest topics
DRRX
News
- DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
DRRX
Earnings
- 11/13/24 - Beat
DRRX
Analyst Actions
- 11/14/24 - HC Wainwright
DRRX
Sec Filings
- 11/29/24 - Form 8-K/A
- 11/25/24 - Form 8-K
- 11/19/24 - Form SC
- DRRX's page on the SEC website